In addition to the name, nominations should include a paragraph substantiating the nomination. The Committee will consider these nominations and will submit nominations themselves. The list will then be narrowed down by the Committee to two to three finalists and the Committee will then select the awardee from that list. The name of the Awardees will be submitted to the Chair of the Program Committee in time for the placement in a prominent position in the Annual Program. The name will also be submitted to the President of the ISAR for his/her letter notifying the recipient of the Award and also notifying the award sponsor of the selection.
Gertrude Elion Memorial Award
The Burroughs Wellcome Fund supports the annual Gertrude Elion Memorial Award by committing funds to ISAR. The award will be conferred at the time of the lecture at the annual conference of the Society. The funds will be used for minimal administrative fees, travel and per diem for the awardee, and the award will be in the amount of $7,500 (the award will be constant, expenses for travel and per diem will vary depending on where the awardee is coming from). The remainder will be kept in escrow for future Elion awards.
The Awards Committee of the ISAR will select the recipient. The award will be given to an outstanding scientist, not necessarily in the field of antiviral research but certainly someone who has made considerable contributions to the scientific field directly or peripheral to it. It should be a senior scientist (basic or clinical) of international stature. If the nominee had some ties to Dr. Elion, this would be considered in a favorable light. The main selection criterion will be scientific prominence. In addition to scientific preeminence, the recipient should have some of the characteristics typical of "Trudy" -- a genuine love of science, not only admired but also respected, a reputation for scientific integrity and approachability, especially to young scientists. The awardee will be asked to give a 45-minute lecture at the annual meeting.
The nominations will be received by the Chairman of the ISAR Awards Committee and reviewed by the Awards Committee, who will make the selection. The President of the Society will notify the awardee, as well as the sponsor, of the selection.
The awardee will be invited to make a presentation at the next International Conference on Antiviral Research, where the award will be presented.
2023 Elion Award Recipient
Fabien Zoulim, MD, PhD
Past Elion Award Recipients
2000 Michael Rossmann
2019 David Evans
2020 Ann Kwong
2021 Wiliam Lee
2022 George Painter
William Prusoff Memorial Award
Bristol-Myers Squibb (BMS) has endowed the William Prusoff Memorial Award, which will be awarded annually by the International Society for Antiviral Research (ISAR). The award will be conferred at the time of the lecture at the annual conference of the Society. The income from the endowment will be used for minimal administrative fees, travel, per diem, a plaque and a cash award for the awardee. The remaining funds will stay in the endowment account for future awards.
ISAR is delighted to honor one of the most talented and beloved members of the Society, Bill Prusoff who has been a loyal member of the Society since its inception. His contributions to the development of antivirals, which have succeeded to clinical use, are legendary; his dedication to mentoring young scientists makes this award in his name truly appropriate.
The Awards Committee will select the recipient. The award will be given to an outstanding young scientist (not older than 45 years of age) who has demonstrated dedication and excellence in the field of antiviral research (basic or clinical, synthetic or pharmacological) and future potential for contribution to the field and the society. The award is intended to encourage young investigators in the field and by definition should not be a fully developed scientist.
The nominations will be received by the Chairman of the ISAR Awards Committee and reviewed by the Committee, who will make the selection. The President of the Society will notify the awardee. as well as the sponsor, of the selection.
The awardee will be invited to make a presentation at the next International Conference on Antiviral Research, where the award will be presented.
2023 Prusoff Award Recipient
Timothy Sheahan, PhD
Past Prusoff Award Recipients
2001 Chris McGuigan
2019 Marnix Van Loock
2020 Jason McLellan
2021 David Durantel
2022 Priscilla Yang
Antonín Holý Memorial Award
Gilead has established sponsorship for the annual Antonín Holý Memorial Award by committing annual funding of $7,500 to the International Society for Antiviral Research (ISAR). The nominee must be a senior scientist of international stature who has made innovative contributions that have had a major impact on antiviral drug discovery and/or development who has demonstrated career-long scientific prominence in medicinal chemistry evidenced by funded research, corporate and/or academic leadership, patents, publications, and presentations. The nominee must have demonstrated service to the field of medicinal chemistry and antiviral research through participation in study sections, membership in editorial boards, and leadership in professional societies. The award will be conferred at the time of the lecture at the annual conference of the Society. The funds will be used for minimal administrative fees, travel and per diem for the awardee, and the award will be in the amount of $5,000 (the award will be constant, expenses for travel and per diem will vary depending on where the awardee is coming from).
The nominations will be received annually by the Chairman of the ISAR Awards Committee and reviewed by that Committee, which will make the selection. The President of the Society will notify the awardee, as well as the sponsor, of the selection.
The awardee will be required to make a presentation at the next International Conference on Antiviral Research, where the award will be presented.
2023 Holý Award Recipient
Vincenzo Summa, PhD
Past Holý Award Recipients
2014 Piet Herdewijn
2019 Richard Mackman
2020 Kathie Seley-Radtke
2021 Eddy Arnold
2022 Mark. von Itzstein
Women and Excellence in Science Award
The International Society for Antiviral Research will issue an Award of Excellence to a woman scientist who has made outstanding contributions to the field of antiviral research. The award will be conferred at the time of the ICAR meeting. The award will be in the amount of $5,000 ($3,000 will be provided to the awardee and the remainder will be used for travel and per diem expenses). The WIS Committee will receive nominations from ISAR members or nominate five female candidate speakers for consideration to participate in a symposium as established by the ICAR Program Committee at the next annual ICAR meeting. The WIS Committee will rank the nominated candidates based on scientific prominence and leadership in their respective scientific area. The WIS Committee will select the WIS Speaker Awardee and an invitation from the WIS Chair to present their research at ICAR will be provided to the awardee.
Eligibility Criteria (WIS Speaker Award)
The awardee will be invited to participate at the next ICAR meeting, where the award will be presented by the WIS Committee Chair.
2023 WIS Speaker Award Recipient
Joanne Lemieux, PhD
Past WIS Speaker Award
2017 Priscilla Yang
2020 Anna Wald
2021 Graciela Andrei
2022 Christina Spiropoulou
Diversity and Excellence in Science Award
The International Society for Antiviral Research (ISAR) has made a commitment to increase diversity in the Society, as well is in the field. The Society will issue a Diversity Speaker Award to a scientist of any group historically underrepresented in our Society who has made outstanding contributions to the field of antiviral research. The Diversity Committee will receive nominations from ISAR members, or nominate candidate speakers for consideration, to participate in a symposium at the annual ICAR meeting. The Diversity Committee will select the Diversity Speaker Awardee based on scientific prominence and leadership in their respective scientific area. The Chair of the Committee will inform the awardee of their selection and invite them to present their research at the annual ICAR meeting, where the award will be presented by the Chair.
2022 Diversity Speaker Award Recipient
Blanton Tolbert, PhD
Past Diversity Speaker Award
2021 Craig Cameron
2022 J. Victor Garcia-Martinez
The Chu Family Foundation Scholarships for Early Career Women in Science
The Chu Family Scholarships were initiated by The Chu Family Foundation (TCFF) and ISAR to support the professional development of early career level women with the potential for significant contribution in the field of antiviral research by providing funds to attend a specialized workshop, visit/work in another laboratory to obtain new skills, take a course, or acquire specialized training.
Up to three awards will be given annually to advance the careers of early career level women with potential for significant contributions in the field of basic, applied, and clinical aspects of antiviral research and antiviral drug development. Each award will consist of a $3,000 stipend, a 2-year ISAR membership and a commemorative plaque. The stipend must be used within a year of its award and the winners must present their research at the next International Conference for Antiviral Research (ICAR). As a result, the award should be used for both the proposed external training and attending the ICAR. However, if the total cost exceeds the $3,000 limit, applicants are still eligible to apply for the ICAR travel award funds. The funds are not meant, however, just to attend ICAR.
To be eligible to apply for the TCFF award, the early career level woman scientist must currently be either a (i) graduate student or (ii) hold a doctoral degree and have no more than four years of cumulative postdoctoral experience. The applicant must currently be doing graduate or postdoctoral research in the general field of antiviral research – this includes virology, chemistry, molecular biology or another virally-related focus. The criteria for selection includes, but is not limited to, the level of interest in antiviral research, the ability to do independent scientific work, the potential for a high level of scientific endeavor in antiviral research, as well as the extent of scientific accomplishments and scientific leadership/mentoring skills. Graduate students and postdoctoral candidates as well as their mentors must be members of ISAR. A letter of support must be provided by a nominator, who may be the candidate’s research project director, Department Chair, or Center Director. Click here for information in how to become an ISAR member.
TCFF Application Process
All grant applications must be submitted electronically by 12:00 PM ET on November 22, 2022. Once submitted, nomination materials become the property of the Selection Committee and will not be returned. Winners will be selected by the TCFF Selection Committee by early-January and will be informed of their status by email. The winners must present their research at the next ICAR meeting. (Note: Winners are still eligible to receive ICAR travel merit and assistance awards to attend ICAR).
Each candidate must submit:
Candidates may apply more than one time but women who have previously won the award are not eligible for a second award. In addition, any candidate that has won a TCFF Scholarship from the International Society of Nucleosides, Nucleotides and Nucleic Acids (IS3NA) is ineligible to apply. In general, the career development activity should not be one for which the applicant's advisor is already funded. After completion of the training or course, etc., the recipient must provide a brief report of the work that was supported by the award to ISAR. This report will then be sent to The Chu Family Foundation.
Nominations for ICAR2023 are no longer being accepted. For questions please contact the TCFF Chair, Professor Katherine Seley- Radtke, with the words The Chu Family Foundation Scholarship in the subject title.
ISAR Award for Outstanding Contributions to the Society
The success of the International Society for Antiviral Research is due to the hard work and devotion of many individuals. However, occasionally an individual stands out as a key factor in the Societies success. Earl Kern is the first recipient of this award which was enacted in 2004. This award is dedicated to one who has made significant contributions consistently over many years (at least 10 years) that are considered to have been essential to the continuing success of the Society and its annual Conference. This rare award is conferred by the ISAR Board upon considerable reflection of the individual’s extensive contributions. These contributions could include, but are not limited to: administrative efforts, efforts considered essential to the success of the Society and its Conference, fund raising activities, membership on committees, recruitment of members, an ambassador and promoter of the society at multiple venues, promotion and/or presentation of the highest quality science at society meeting, promotion of the effective integration of industry and academic society members, etc.
Outstanding Contributions Award Recipients
Earl R. Kern presented in 2004
Mark Prichard presented in 2019
From time to time the International Society for Antiviral Research will issue the prestigious Award of Excellence to individuals who have made truly outstanding contributions to the field of antiviral research. The Board of Directors in conjunction with the Awards Committee makes the selection. Past recipients have been: Erik DeClercq, Gertrude Elion, William Prusoff, Richard J. Whitley, and Robert Gallo.
Conference Poster Awards
The International Society for Antiviral Research presents awards for excellence in scientific poster presentations at the annual Conference. The awards will be presented to recognize young investigators for their outstanding contributions to antiviral research. Awards will be based on criteria including scientific excellence, innovative research methodology, clarity and organization of presentation materials, and competence of the investigator in responding to the poster audience. Award recipients will be chosen by the Poster Award Subcommittee, a panel of ISAR members; with first and second prize awards presented for each of the following categories:
Category 1: Graduate students (Pre-Ph.D or equivalent degree)
You must present your poster in-person to be eligible for the Poster Awards. Virtual only posters will not be considered for a poster award. Participants in the awards competition will identify the appropriate category on the poster board during the poster presentation. Abstracts chosen for oral presentations will be eligible for an award if a poster is also submitted.
Congratulations to the ICAR2022 Poster Award Winners!